Teva Canada Limited v. Pfizer Canada Inc., 2014 FC 248 (Venlafaxine*)
Justice Zinn - 2014-04-03
Read full decision. Automatically generated summary:
This is an action for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 [the PMNOC Regulations].
Teva Canada Limited is the corporate successor to the original plaintiff, ratiopharm inc. [Ratiopharm]. The Defendant, Pfizer Canada Inc. [Pfizer] is the corporate successor to the original defendants, Wyeth and Wyeth Canada [Wyeth].
Decision relates to:
- T-1844-07 - RATIOPHARM INC. v. WYETH, WYETH CANADA